Clinical Efficacy of PD-1 Inhibitors Plus Split-Course Radiotherapy in the First-Line Treatment of Advanced Kidney Cancer: A Randomized Controlled Trial

OBJECTIVE: To assess the clinical efficacy of programmed death 1 (PD-1) inhibitors plus split-course radiotherapy in the first-line treatment of advanced kidney cancer. METHODS: In this prospective, randomized, single-blinded, controlled trial, 44 patients with advanced kidney cancer initially treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Weiping, Cao, Zhigang, Chang, Pengcheng, Zhang, Bin, Li, Fudong, Chang, Dehui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356868/
https://www.ncbi.nlm.nih.gov/pubmed/35942408
http://dx.doi.org/10.1155/2022/8100323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356868/
https://www.ncbi.nlm.nih.gov/pubmed/35942408
http://dx.doi.org/10.1155/2022/8100323

Ejemplares similares